Oncopeptides AB (ONCO.ST) Q3 2024 Earnings

14AugConfirmed
Q3 2023
Q4 2023
Q2 2024
Q3 2024
-0.74
-0.51
-0.28
-0.05

Details

Expected EPS
N/A
Actual EPS
-0.045072
Surprise EPS
-0.05
Surprise Percent
+∞%

Description

Oncopeptides AB (ONCO.ST) has reported earnings of -0.045072 per share for Q3 2024.

0 Comments

Share your thoughts